Revenue from operations margianlly shed 0.38% year on year (YoY) to Rs 60.04 crore in the quarter ended 31 March 2026.

Profit before tax (PBT) stood at Rs 18.44 crore in Q4 FY26, down 31.50% from Rs 26.92 crore recorded in the same quarter last year.

Total expenses jumped 20.42% YoY to Rs 43.74 crore in Q4 FY26. The cost of materials consumed stood at Rs 4.04 crore (up 110.41% YoY), while employee benefit expenses rose 80.61% YoY to Rs 11.74 crore during the period under review.

The company recommended a dividend of Rs 2.40 per equity share of face value Rs 2 each (120%) for FY26.

Alembic is dealing in Active Pharmaceutical Ingredient (API) Business and Real Estate Business.